Citigroup’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$438K Sell
29,261
-54,203
-65% -$811K ﹤0.01% 3011
2025
Q1
$1.35M Buy
83,464
+9,712
+13% +$157K ﹤0.01% 2367
2024
Q4
$1.72M Buy
73,752
+48,561
+193% +$1.13M ﹤0.01% 2231
2024
Q3
$741K Buy
25,191
+5,871
+30% +$173K ﹤0.01% 2757
2024
Q2
$454K Sell
19,320
-12,437
-39% -$292K ﹤0.01% 2760
2024
Q1
$1.2M Buy
31,757
+21,460
+208% +$814K ﹤0.01% 2229
2023
Q4
$222K Buy
+10,297
New +$222K ﹤0.01% 3132
2022
Q4
Sell
-25
Closed 5041
2022
Q3
$0 Sell
25
-182
-88% ﹤0.01% 5385
2022
Q2
$3K Buy
207
+34
+20% +$493 ﹤0.01% 5007
2022
Q1
$10K Sell
173
-303
-64% -$17.5K ﹤0.01% 4763
2021
Q4
$56K Buy
476
+191
+67% +$22.5K ﹤0.01% 4239
2021
Q3
$57K Buy
285
+86
+43% +$17.2K ﹤0.01% 3929
2021
Q2
$35K Buy
199
+35
+21% +$6.16K ﹤0.01% 4318
2021
Q1
$33K Sell
164
-239
-59% -$48.1K ﹤0.01% 4287
2020
Q4
$79K Buy
403
+209
+108% +$41K ﹤0.01% 3834
2020
Q3
$34K Sell
194
-153
-44% -$26.8K ﹤0.01% 3692
2020
Q2
$80K Sell
347
-27
-7% -$6.23K ﹤0.01% 3582
2020
Q1
$44K Buy
374
+70
+23% +$8.24K ﹤0.01% 3879
2019
Q4
$58K Buy
304
+199
+190% +$38K ﹤0.01% 3867
2019
Q3
$20K Sell
105
-193
-65% -$36.8K ﹤0.01% 4281
2019
Q2
$51K Buy
298
+70
+31% +$12K ﹤0.01% 4080
2019
Q1
$46K Buy
228
+60
+36% +$12.1K ﹤0.01% 4081
2018
Q4
$32K Sell
168
-11
-6% -$2.1K ﹤0.01% 4181
2018
Q3
$43K Buy
179
+85
+90% +$20.4K ﹤0.01% 4171
2018
Q2
$25K Buy
+94
New +$25K ﹤0.01% 4299